outcomes research

Venetoclax Response in Patients With R/R CLL

06/15/2016

JCP Editors

Patients with chronic lymphocytic leukemia (CLL) who are relapsed or refractory (R/R) to ibrutinib or idelalisib may benefit from venetoclax monotherapy, according to a study presented at the 2016 American Society of...

...

06/15/2016

Journal of Clinical Pathways

Research in Review

Outcomes of Treating ALL With Inotuzumab Ozogamicin

06/14/2016

JCP Editors

A clinical trial assessing the use of inotuzumab ozogamicin in patients with acute lymphoblastic leukemia (ALL) has found that it may be a more effective treatment option than current standard practice. Inotuzumab...

A...

06/14/2016

Journal of Clinical Pathways

Non-Platinum-Based Chemo May Worsen Survival in Ovarian Cancer

06/10/2016

JCP Editors

Prolonging platinum-free interval (PFI) by introducing non-platinum-based chemotherapy may actually worsen efficacy outcomes in patients with recurrent ovarian cancer, according to clinical trial results presented at...

...

06/10/2016

Journal of Clinical Pathways

Transplant Still Preferred Treatment Choice in Young Patients With Myeloma

05/31/2016

JCP Editors

Autologous stem cell transplantation (ASCT) is still the preferred treatment of choice for patients under the age of 65 years with newly diagnosed multiple myeloma (NDMM), according to early results from a phase 3...

...

05/31/2016

Journal of Clinical Pathways

Treatment Protocol for Pancreatic Cancer May Improve Survival

05/28/2016

JCP Editors

Patients with pancreatic cancer formally believed to not be eligible for surgery may in fact benefit from resection, according to findings from two recent studies.   Pancreatic cancer can be an especially...

...

05/28/2016

Journal of Clinical Pathways

Research in Review

Breast Cancer Biomarker of Chemotherapy Resistance Identified

05/26/2016

JCP Editors

Expression of methylation-controlled J protein (MCJ) may be an indicator of successful outcomes and reduced risk of relapse in patients with breast cancer, according to a recent study. Chemotherapy is a key part of...

...

05/26/2016

Journal of Clinical Pathways

Research in Review

Weight Gain a Sign of Successful Treatment in Patients With NSCLC

05/24/2016

JCP Editors

Weight gain may be an indicator of successful treatment for patients with non-small cell lung cancer (NSCLC), according to findings from a recently published article. Past studies have linked unintentional weigh...

Weight...

05/24/2016

Journal of Clinical Pathways

Research in Review

Surgery Offers Survival Benefit to Older Patients With Lung Cancer

05/12/2016

JCP Editors

Patients 65 years and older who receive surgery for lung cancer are living longer, claims a recent study. According to national records, lung cancer most commonly occurs in older adults, with the median age at...

...

05/12/2016

Journal of Clinical Pathways

From the Field

Mock Clinical Pathways: A Method for Exploring the Oncology Clinical Pathway Development Process

05/06/2016

Bruce Feinberg, DO

Monica Lingam, MS

Bing-E Xu, PhD

Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care as well as to make costs and outcomes more predictable, measurable, and accountable. A mock clinical...

...

05/06/2016

Journal of Clinical Pathways

SBRT for Patients With NSCLC Linked to Higher Rates of Non-Cancer Death

05/04/2016

JCP Editors

Using stereotactic body radiation therapy (SBRT) to treat patients with non-small cell lung cancer (NSCLC) may slightly increase the risk of dying from a cause other than cancer, according to research presented at...

Using...

05/04/2016

Journal of Clinical Pathways